J. Morgan

发表

Predictors of Frequent Emergency Room Visits among a Homeless Population

M. Drainoni, J. Gaeta, K. Thakarar, 2015, PloS one.

Cost-effectiveness of HCV Treatment Models for People Who Inject Drugs in Opioid Agonist Treatment Programs.

B. Schackman, B. Linas, Sean M. Murphy, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Cost-effectiveness of hepatitis C screening and treatment linkage intervention in US methadone maintenance treatment programs.

K. Delucchi, B. Schackman, B. Linas, 2018, Drug and alcohol dependence.

The Determining Effective Testing in Emergency Departments and Care Coordination on Treatment Outcomes (DETECT) for Hepatitis C (Hep C) Screening Trial: rationale and design of a multi-center pragmatic randomized clinical trial of hepatitis C screening in emergency departments

Matthew F. Toerper, M. Saheed, M. Lyons, 2022, Trials.

The Effect of Shorter Treatment Regimens for Hepatitis C on Population Health and Under Fixed Budgets

B. Linas, S. Naggie, A. Kim, 2017, Open forum infectious diseases.

Eligibility for cervical cancer screening exit: Comparison of a national and safety net cohort.

J. Morgan, R. Perkins, J. M. Mills, 2021, Gynecologic oncology.

Cost-effectiveness of integrating buprenorphine-naloxone treatment for opioid use disorder into clinical care for persons with HIV/hepatitis C co-infection who inject opioids.

K. Freedberg, M. Stein, B. Schackman, 2019, The International journal on drug policy.

Payments for outpatient joint replacement surgery: A comparison of hospital outpatient departments and ambulatory surgery centers.

K. Carey, J. Morgan, 2020, Health services research.

Decision analysis of strategies to identify hepatitis C Predictive Modelling

B. Linas, J. Morgan, 2017 .

Medicaid Hepatitis C Virus Treatment Policies: Impact on Testing and Treatment in the Commercially Insured.

Laura F. White, B. Linas, S. Kapadia, 2022, American journal of preventive medicine.

Impact of prenatal substance use policies on commercially insured pregnant females with opioid use disorder

A. Jalali, S. Kapadia, J. Morgan, 2022, Journal of substance abuse treatment.

The role of increasing pharmacy and community distributed naloxone in the opioid overdose epidemic in Massachusetts, Rhode Island, and New York City

Brandon D. L. Marshall, A. Jalali, B. Linas, 2022, Drug and alcohol dependence reports.

Disproportionate Exposure to Antibiotics in Children at Risk for Invasive Pneumococcal Disease: Potential for Emerging Resistance and Opportunity for Antibiotic Stewardship

S. Pelton, W. Kaplan, K. Outterson, 2019, Journal of the Pediatric Infectious Diseases Society.

Health economic design for cost, cost-effectiveness and simulation analyses in the HEALing Communities Study

G. Zarkin, E. Seiber, J. Chhatwal, 2020, Drug and Alcohol Dependence.

Opioid Use Disorder and Overdose Among Youth Following an Initial Opioid Prescription.

Scott E. Hadland, J. Barocas, J. Morgan, 2021, Addiction.

Targeting community-based naloxone distribution using opioid overdose death rates: A descriptive analysis of naloxone rescue kits and opioid overdose deaths in Massachusetts and Rhode Island.

B. Schackman, B. Marshall, Sean M. Murphy, 2021, The International journal on drug policy.

Epidemic of AIDS related virus infection among intravenous drug abusers.

J. Morgan, T. Mcmanus, G. Webb, 1986, British medical journal.

Determining the lower limit of detection required for HCV viral load assay for test of cure following direct‐acting antiviral‐based treatment regimens: Evidence from a global data set

P. Easterbrook, W. Elakel, G. Esmat, 2022, Journal of viral hepatitis.

Evaluating equity in community-based naloxone access among racial/ethnic groups in Massachusetts.

Brandon D. L. Marshall, B. Schackman, B. Linas, 2022, Drug and alcohol dependence.

Prevalence of HIV Preexposure Prophylaxis Prescribing Among Persons With Commercial Insurance and Likely Injection Drug Use

M. Paasche-Orlow, Marc R. Larochelle, Jessica L. Taylor, 2022, JAMA network open.

Estimating Absenteeism Related to Nonalcohol Substance Use in a US National Cohort of Full-Time Employees

B. Linas, Sean M. Murphy, S. Assoumou, 2022, Journal of occupational and environmental medicine.

Opioid overdose and inpatient care for substance use disorder care in Massachusetts.

B. Linas, M. Bharel, A. Walley, 2020, Journal of substance abuse treatment.

Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured cohort.

B. Schackman, B. Linas, A. Walley, 2019, Drug and alcohol dependence.

Homelessness, HIV, and Incomplete Viral Suppression

M. Drainoni, J. Gaeta, K. Thakarar, 2016, Journal of health care for the poor and underserved.

The Cost-Effectiveness of Sofosbuvir-Based Regimens for Treatment of Hepatitis C Virus Genotype 2 or 3 Infection

M. Weinstein, K. Freedberg, J. Salomon, 2015, Annals of Internal Medicine.

Variation in Initiation, Engagement, and Retention on Medications for Opioid Use Disorder Based on Health Insurance Plan Design

E. Quinn, Laura F. White, B. Linas, 2022, Medical care.

Estimated Prevalence of Opioid Use Disorder in Massachusetts, 2011-2015: A Capture-Recapture Analysis

Laura F White, Benjamin P Linas, T. Land, 2018, American journal of public health.

Economic evaluation of HCV testing approaches in low and middle income countries

P. Easterbrook, B. Linas, J. Morgan, 2017, BMC Infectious Diseases.

Outcomes Associated with Medications for Opioid Use Disorder Among Persons Hospitalized for Infective Endocarditis.

M. Stein, A. Wurcel, J. Barocas, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Underscreenng, overscreening, and guideline-adherent cervical cancer screening in a national cohort.

J. Morgan, R. Perkins, S. Fiascone, 2022, Gynecologic oncology.

Using Medical Claims for Policy Effectiveness Surveillance: Reimbursement and Utilization of Abdomen/Pelvis Computed Tomography Scans.

M. Horný, V. Merker, J. Morgan, 2015, Health services research.

Gynecologic Outcomes After Hysteroscopic and Laparoscopic Sterilization Procedures

M. Paasche-Orlow, Shaalini Ramanadhan, J. Morgan, 2016, Obstetrics and gynecology.

Patient Outcomes Following Total Joint Replacement Surgery: A Comparison of Hospitals and Ambulatory Surgery Centers.

K. Carey, W. Creevy, Michael S. H. Kain, 2018, The Journal of arthroplasty.

Antibiotics for Respiratory Tract Infections: A Comparison of Prescribing in an Outpatient Setting

C. Christiansen, T. Barlam, M. Drainoni, 2014, Infection Control & Hospital Epidemiology.

Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population.

Benjamin P Linas, Bruce R Schackman, B. Schackman, 2018, Journal of substance abuse treatment.

Cost Effectiveness and Cost Containment in the Era of Interferon-Free Therapies to Treat Hepatitis C Virus Genotype 1

M. Weinstein, K. Freedberg, J. Salomon, 2016, Open forum infectious diseases.

Coal power plant emission exposure and its effect on education access

A. Bekkerman, J. Morgan, 2014, Journal of Public Health.

The Determining Effective Testing in Emergency Departments and Care Coordination on Treatment Outcomes (DETECT) for Hepatitis C (Hep C) Linkage-to-Care Trial: rationale and design of an emergency department-based randomized clinical trial of linkage-to-care strategies for hepatitis C

Matthew F. Toerper, M. Saheed, J. Haukoos, 2023, Trials.

Characterizing initiation, use, and discontinuation of extended-release buprenorphine in a nationally representative United States commercially insured cohort.

B. Linas, Scott E. Hadland, Sean M. Murphy, 2021, Drug and alcohol dependence.

Comparison of Rates of Overdose and Hospitalization After Initiation of Medication for Opioid Use Disorder in the Inpatient vs Outpatient Setting

M. Stein, B. Schackman, B. Linas, 2020, JAMA network open.

TRACKING THE LITTLE BLACK \RAIN" CLOUDS: AN ENVIRO-ECONOMIC ANALYSIS OF AMBIENT AIR POLLUTION EFFECTS ON PEDIATRIC ASTHMA

J. Morgan, 2012 .

Will converting naloxone to over‐the‐counter status increase pharmacy sales?

B. Schackman, Sean M. Murphy, Philip J Jeng, 2019, Health services research.

Buprenorphine Uptake During Pregnancy Following the 2017 Guidelines Update on Prenatal Opioid Use Disorder.

Zachary F. Meisel, J. Morgan, Angélica Meinhofer, 2022, American journal of obstetrics and gynecology.

Projected Estimates of Opioid Mortality After Community-Level Interventions

B. Schackman, B. Linas, Sean M. Murphy, 2021, JAMA network open.

Broadening access to naloxone: Community predictors of standing order naloxone distribution in Massachusetts

R. Pollini, Z. Xuan, A. Walley, 2022, Drug and Alcohol Dependence.

An Interrupted Continuum of Care? What are the Risk Factors andComorbidities Related to Long-Term Engagement and Retention in HIVCare?

C. Christiansen, K. Carey, M. Drainoni, 2015 .

Community-based Naloxone Coverage Equity for the Prevention of Opioid Overdose Fatalities in Racial/Ethnic Minority Communities in Massachusetts and Rhode Island.

Brandon D. L. Marshall, B. Schackman, B. Linas, 2021, Addiction.

Getting What You Pay For: The Economics of Quality Care for Sexually Transmitted Infections

K. Hsu, M. Drainoni, M. Sullivan, 2016, Sexually transmitted diseases.

Characteristics of patients who accept and decline ED rapid HIV testing.

P. Mitchell, E. Schechter-Perkins, M. Drainoni, 2014, The American journal of emergency medicine.

HCV Viral Load Greater Than 1000 IU/ml at Time of Virologic Failure in Direct-Acting Antiviral-Treated Patients

B. Linas, Zhenyi Xue, Sonjelle Shilton, 2021, Advances in Therapy.

Optimizing timing of adolescent vaccines: Impact of initiating HPV vaccination before Tdap or meningococcal vaccination on timely completion of the HPV vaccine series

J. Morgan, R. Perkins, S. Fiascone, 2023, Human vaccines & immunotherapeutics.

Inappropriate Antibiotic Prescribing for Acute Bronchitis in Children and Impact on Subsequent Episodes of Care and Treatment

C. Christiansen, K. Carey, T. Barlam, 2019, The Pediatric infectious disease journal.

Potential barriers to filling buprenorphine and naltrexone prescriptions among a retrospective cohort of individuals with opioid use disorder.

E. Quinn, Laura F. White, C. Chaisson, 2021, Journal of substance abuse treatment.

Implementation of A Nationwide Health Economic Consultation Service to Assist Substance Use Researchers: Lessons Learned

B. Schackman, B. Linas, Sean M. Murphy, 2018, Substance abuse.

Patient-Provider Race and Sex Concordance: New Insights into Antibiotic Prescribing for Acute Bronchitis

C. Christiansen, T. Barlam, M. Drainoni, 2017 .

Comparison of a national commercial pharmacy naloxone data source to state and city pharmacy naloxone data sources-Rhode Island, Massachusetts, and New York City, 2013-2019.

Brandon D. L. Marshall, Z. Xuan, Sean M. Murphy, 2023, Health services research.

Incidence of Gynecologic Cancers in Women After Uterine Artery Embolization.

M. Paasche-Orlow, J. Morgan, R. Perkins, 2020, Journal of minimally invasive gynecology.

Matthew F. Toerper, M. Saheed, M. Lyons, 2022, Trials.

A Qualitative Study of the Real-world Experiences of Infectious Diseases Fellows Regarding Antibiotic Stewardship

T. Barlam, M. Drainoni, J. Morgan, 2018, Open forum infectious diseases.

Population-level impact of initiating pharmacotherapy and linking to care persons with opioid use disorder at inpatient medically managed withdrawal programs: an effectiveness and cost-effectiveness analysis.

B. Linas, Sean M. Murphy, S. Assoumou, 2022, Addiction.